ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

The Ohio State University Wexner Medical Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

The Ohio State University Wexner Medical Center takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans liquid biopsy methods in early drug development and treatments for gynaecological cancers. It covers trials of pembrolizumab with radiation for endometrial cancer and mocertatug rezetecan for platinum-resistant ovarian cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Academic medical centre of Ohio State University in Columbus, Ohio, including its cancer hospital and research institute.
Talk
Fri Oct 23
16:15–16:35
Presentation by Expert
Use of liquid biopsies in early drug development: Are we ready for it?
Biomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at The Ohio State University Wexner Medical Center

Tell us what you sell and we’ll find the people at The Ohio State University Wexner Medical Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction